yttrium radioisotopes has been researched along with Adenocarcinoma in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (5.26) | 18.7374 |
1990's | 13 (22.81) | 18.2507 |
2000's | 23 (40.35) | 29.6817 |
2010's | 15 (26.32) | 24.3611 |
2020's | 3 (5.26) | 2.80 |
Authors | Studies |
---|---|
Karamchandani, DM; Pantaleon Vasquez, R | 1 |
Alexander, HC; Bartlett, ASJR; Chu, MJJ; Han, CH; Holden, AH; Nguyen, CH; Tarr, GP; Thomas, RH | 1 |
Choi, J; El-Haddad, G; Frakes, J; Kayaleh, R; Kis, B; Krzyston, H; Naziri, J; Parikh, N; Rishi, A; Sweeney, J | 1 |
Avery, RJ; Hennemeyer, CT; Kuo, PH; Nia, BB; Nia, ES | 1 |
Bagwan, IN; Balamurugan, T; Hussain, F | 1 |
Akhter, N; Brower, J; Frantz, S; Kim, AY | 1 |
Bagwan, IN; Kurian, RR; Preston, SR | 1 |
Brody, LA; Capanu, M; Carrasquillo, JA; Chou, JF; Do, KG; Garcia, AR; Kemeny, NE; Longing, AP; Pandit-Taskar, N; Petre, EN; Sofocleous, CT | 1 |
Arbizu, J; Domínguez-Prado, I; Elosúa, C; García-Velloso, MJ; Martí-Climent, JM; Peñuelas, I; Prieto, E; Richter, JA; Rodríguez-Fraile, M; Vigil, C | 1 |
Bahary, N; Braiteh, FS; Bridges, BB; Cohen, SJ; Conkling, PR; Dragovich, T; Frank, RC; Goldenberg, DM; Goldsmith, SJ; Gribbin, TE; Guarino, MJ; Horne, H; Intenzo, CM; Korn, RL; Lee, FC; Lee, M; Lowery, MA; Manzone, TC; Mitchel, EP; O'Neil, BH; O'Reilly, EM; Ocean, AJ; Pandit-Taskar, N; Picozzi, VJ; Ramanathan, RK; Richards, DA; Sharkey, RM; Sheikh, A; Starodub, AN; Von Hoff, DD; Wegener, WA | 1 |
Maas, L | 1 |
Alsaikhan, N; Ball, DS; Cohen, SJ; Cohn, M; Coldwell, DM; Drooz, A; Ehrenwald, E; Hoh, CK; Kanani, S; Kennedy, AS; Minocha, J; Moeslein, FM; Narsinh, KH; Nutting, CW; Putnam, SG; Rose, SC; Savin, MA; Schirm, S; Sharma, NK; Suhail, M; Thurston, K; Van Buskirk, M; Wang, EA | 1 |
Bartlett, DL; Chung, MH; Doherty, MG; Marsh, JW; Varma, MK; Wright, GP | 1 |
Georgiades, CS; Geschwind, JF; Herman, JM; Hong, K; Kamel, IR; McBride, JD; Reyes, DK | 1 |
De Keukeleire, K; Defreyne, L; Delatte, P; Delaunoit, T; Flamen, P; Hendlisz, A; Lambert, B; Maleux, G; Paesmans, M; Peeters, M; Personeni, N; Van Cutsem, E; Van den Eynde, M; Van Laethem, JL; Vannoote, J; Verslype, C | 1 |
Bester, L; Goldstein, D; Sjoquist, KM | 1 |
Caridi, J; George, TJ; Liu, C; Nair, J; Zlotecki, R | 1 |
Forero, A; LoBuglio, AF; Meredith, RF; Shen, S | 1 |
Hill, EJ; Jani, AR; Sharma, RA; Wang, LM | 1 |
Alvarez, RD; Austin, JM; Barnes, MN; Carey, D; Grizzle, WE; Huh, WK; Khazaeli, MB; Kilgore, LC; LoBuglio, AF; Meredith, RF; Partridge, EE; Schlom, J; Shen, S | 1 |
Barrett, J; Bartis, J; Bozarth, J; Edwards, S; Ellars, C; Harris, TD; Kalogeropoulos, S; Lazewatsky, J; Liu, S; Nguyen, T; Onthank, D; Robinson, S; Silva, P; Yalamanchili, P | 1 |
Cardillo, TM; Gold, DV; Modrak, DE; Schutsky, K | 1 |
Jones, B; Nutting, C; Rubin, D | 1 |
Bailey, W; Dowling, R; Gibbs, P; Liechtenstein, M; Lim, L; Little, A; Shapiro, JD; Smith, D; Yip, D | 1 |
Axworthy, DB; Besh, S; Breitz, H; Chen, KH; Forero-Torres, A; Khazaeli, MB; LoBuglio, AF; Meredith, RF; Percent, I; Shen, S; Sims, RB | 1 |
Abe, M; Baranowska-Kortylewicz, J; Enke, CA; Kortylewicz, ZP; Kurizaki, T; Mosley, RL; Nearman, J; Ostman, A; Paulsson, J; Pietras, K | 1 |
Ayav, A; Habib, N; Jiao, LR | 1 |
Kennedy, AS; Thomadsen, B; Welsh, JS | 1 |
Berry, DP; Blanshard, K; Bower, G; Gibbs, P; Morgan, B; Price, D; Shannon, JA; Sharma, RA; Steward, WP; Van Hazel, GA | 1 |
Brown, DB; Censullo, M; Cohen, AM; Coldwell, DM; Habbu, A; Krishnan, S; Liu, D; Meranze, SG; Murthy, R; Nunez, R; Ross, W; Salem, R | 1 |
Buckland, ME; Gilbert, DR; Newland, LR; Walsh, A | 1 |
Abdel-Misih, R; Dignazio, M; Garcia, M; Khatri, J; Neff, R; Petrelli, N; Wilson, P | 1 |
Erhardt, A; Häussinger, D; Mallach, S; Ramp, U; Schmitt, M | 1 |
Blumenthal, RD; Goldenberg, DM; Kashi, R; Sharkey, RM | 1 |
Blumenthal, R; Goldenberg, DM; Sharkey, RM; Stein, R | 1 |
Goris, ML; Knox, SJ; Langmuir, VK; Mendonca, HL; Wilder, RB | 1 |
Buchsbaum, DJ; Heidorn, DB; Lawrence, TS; Roberson, PL; Steplewski, Z; Ten Haken, RK | 1 |
Chinol, M; Fazio, F; Meares, C; Paganelli, G; Sudati, F | 1 |
DeNardo, GL; DeNardo, SJ; Gumerlock, PH; Kroger, LA; Kukis, DL; Lamborn, KR; Meares, CF; Miers, LA; Salako, Q; Shen, S; Winthrop, MD | 1 |
Angelberger, P; Bischof, C; Gludovacz, D; Hamilton, G; Kaserer, K; Kofler, A; Leimer, M; Pangerl, T; Peck-Radosavljevic, M; Schlangbauer-Wadl, H; Smith-Jones, PM; Traub, T; Virgolini, I | 1 |
Axworthy, DB; Beaumier, PL; Breitz, HB; Bryan, K; Graves, S; Reno, JM; Seiler, C; Su, FM; Weiden, PL | 1 |
Austin, JC; Gerstbrein, J; Kahn, D; Maguire, RT; Miller, SJ; Williams, RD | 1 |
Breitz, HB; Fisher, DR; Goris, ML; Knox, S; Murtha, AD; Ratliff, B; Weiden, PL | 1 |
Anderson, J; Augustine, S; Baranowska-Kortylewicz, J; Colcher, D; Harrison, K; Leichner, P; Schlom, J; Tempero, M; Wisecarver, J | 1 |
Brechbiel, MW; Clarke, K; Lee, FT; Old, LJ; Scott, AM; Smyth, FE | 1 |
Goodwin, DA; Hays, M; Lubic, SP; Meares, CF; Osen, M; Song, C | 1 |
DeNardo, GL; DeNardo, SJ; Goldstein, DS; Griffith, IJ; Kukis, DL; Lara, PN; Martinez, GS; Meyers, FJ; Mirick, GR; O'Donnell, RT; Richman, CM; Shen, S; Yuan, A | 1 |
Begent, RH; Boden, R; Boxer, GM; Flynn, AA; Green, AJ; Pedley, RB | 1 |
Anderson, J; Burton, M; Gebski, V; Gray, B; Hope, M; Moroz, P; Van Hazel, G | 1 |
Brechbiel, MW; Garmestani, K; Milenic, DE; Plascjak, PS | 1 |
Crumbley, AJ; Grady, ED; Nolan, TR; Rosen, AR | 1 |
Anderson, JE; Burton, MA; Codde, J; Gray, BN; Klemp, P; Morgan, C; van Hazel, G | 1 |
Demidecki, AJ; Wessels, BW; Williams, LE; Wong, JY; Yan, XW | 1 |
Battifora, H; Beatty, JD; Esteban, JM; Felder, B; Kuhn, JA; Shively, JE; Wanek, PM; Wong, JY | 1 |
Burton, MA; Gray, BN; Kelleher, D; Klemp, P; Matz, L | 1 |
Burton, MA; Gray, BN; Hardy, N; Kelleher, DK; Klemp, PF | 1 |
Anderson, J; Burton, MA; Gray, BN; Kelleher, DK; Klemp, P | 1 |
3 review(s) available for yttrium radioisotopes and Adenocarcinoma
Article | Year |
---|---|
Transarterial Radioembolization for Hepatic Metastases of Pancreatic Adenocarcinoma: A Systematic Review.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Embolization, Therapeutic; Humans; Liver Neoplasms; Pancreatic Neoplasms; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
A serious complication of selected internal radiation therapy: case report and literature review.
Topics: Adenocarcinoma; Colorectal Neoplasms; Gastric Mucosa; Humans; Male; Middle Aged; Radiation Injuries; Stomach Ulcer; Yttrium Radioisotopes | 2010 |
Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
Topics: Adenocarcinoma; Algorithms; Brachytherapy; Cell Hypoxia; Colorectal Neoplasms; Humans; Liver; Liver Neoplasms; Microspheres; Radiation Injuries; Radiotherapy Dosage; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2006 |
11 trial(s) available for yttrium radioisotopes and Adenocarcinoma
Article | Year |
---|---|
Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Colorectal Neoplasms; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Yttrium Radioisotopes | 2014 |
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Deoxycytidine; Disease Progression; Feasibility Studies; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mucins; Pancreatic Neoplasms; Radioimmunotherapy; Radiopharmaceuticals; Remission Induction; Thrombocytopenia; Time Factors; Treatment Outcome; United States; Yttrium Radioisotopes | 2015 |
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2010 |
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antibodies, Heterophile; Antibodies, Monoclonal; Antibodies, Neoplasm; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Immunoconjugates; Injections, Intraperitoneal; Maximum Tolerated Dose; Mice; Middle Aged; Ovarian Neoplasms; Radioimmunotherapy; Treatment Outcome; Yttrium Radioisotopes | 2002 |
Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies.
Topics: Adenocarcinoma; Aged; Australia; Carcinoma, Hepatocellular; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Biotin; Clinical Trials as Topic; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Gamma Cameras; Gastrointestinal Neoplasms; Glycoproteins; Humans; Indium Radioisotopes; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Radioimmunotherapy; Radioisotopes; Radiometry; Radiopharmaceuticals; Recombinant Fusion Proteins; Rhenium; Streptavidin; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Australia; Brachytherapy; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Maximum Tolerated Dose; Microspheres; Middle Aged; Organoplatinum Compounds; Radiopharmaceuticals; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; United Kingdom; Vitamin B Complex; Yttrium Radioisotopes | 2007 |
A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Marrow; Combined Modality Therapy; Edetic Acid; Gonadotropin-Releasing Hormone; Humans; Immunoconjugates; Leukopenia; Male; Middle Aged; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiation Injuries; Radioimmunodetection; Salvage Therapy; Soft Tissue Neoplasms; Thrombocytopenia; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Yttrium Radioisotopes | 1999 |
High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Biopsy; Dose-Response Relationship, Radiation; Female; Gastrointestinal Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Immunotoxins; Indium Radioisotopes; Male; Middle Aged; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2000 |
Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Animals; Antibodies, Monoclonal; Cohort Studies; Combined Modality Therapy; Humans; Indium Radioisotopes; Male; Mice; Middle Aged; Neoplasm Metastasis; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunotherapy; Radiometry; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2001 |
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Floxuridine; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Quality of Life; Risk Factors; Treatment Outcome; Yttrium Radioisotopes | 2001 |
43 other study(ies) available for yttrium radioisotopes and Adenocarcinoma
Article | Year |
---|---|
Yttrium-90 Microsphere Selective Internal Radiation Therapy-Induced Cholecystitis.
Topics: Adenocarcinoma; Aged; Brachytherapy; Cholecystectomy; Cholecystitis; Colonic Neoplasms; Gallbladder; Gallstones; Humans; Liver Neoplasms; Male; Microspheres; Radiation Injuries; Ultrasonography; Yttrium Radioisotopes | 2020 |
Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective Study.
Topics: Adenocarcinoma; Aged; Disease Progression; Embolization, Therapeutic; Female; Glass; Humans; Male; Microspheres; Middle Aged; Pancreatic Neoplasms; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Time Factors; Yttrium Radioisotopes | 2020 |
Punctate Radiation Dermatitis of the Foot and Ankle Caused by Distal Embolization of 90Y Microspheres During Liver Directed Therapy.
Topics: Adenocarcinoma; Adult; Ankle; Dermatitis; Embolization, Therapeutic; Foot; Humans; Liver Neoplasms; Male; Microspheres; Radiation Injuries; Radiometry; Stomach Neoplasms; Yttrium Radioisotopes | 2017 |
Microspheres in gall bladder.
Topics: Adenocarcinoma; Adult; Brachytherapy; Cholecystectomy; Cholecystitis; Embolization, Therapeutic; Female; Gallbladder; Hepatectomy; Humans; Liver Neoplasms; Microspheres; Rectal Neoplasms; Yttrium Radioisotopes | 2017 |
Radioembolization with Yttrium-90 Microspheres for the Treatment of Liver Metastases of Pancreatic Adenocarcinoma: A Multicenter Analysis.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; United States; Yttrium Radioisotopes | 2019 |
Iatrogenic gastric ulceration.
Topics: Adenocarcinoma; Adult; Brachytherapy; Colonic Neoplasms; Fatal Outcome; Humans; Iatrogenic Disease; Liver Neoplasms; Male; Microspheres; Radiation Injuries; Stomach; Stomach Ulcer; Yttrium Radioisotopes | 2013 |
PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.
Topics: Adenocarcinoma; Aged; Brachytherapy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Computer Simulation; Embolization, Therapeutic; Esophageal Neoplasms; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Phantoms, Imaging; Positron-Emission Tomography; Radiation Dosage; Signal-To-Noise Ratio; Tissue Distribution; Yttrium Radioisotopes | 2014 |
Yttrium-90 radioembolization as a palliative treatment for liver tumors: a case study.
Topics: Adenocarcinoma; Colonic Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Middle Aged; Palliative Care; Yttrium Radioisotopes | 2015 |
Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with
Topics: Adenocarcinoma; Adult; Aged; Angiography; Arteriovenous Fistula; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver; Lung; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Eye Neoplasms; Hepatectomy; Humans; Length of Stay; Liver Neoplasms; Melanoma; Middle Aged; Neuroendocrine Tumors; Patient Readmission; Postoperative Complications; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2017 |
Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemoembolization, Therapeutic; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Gastroduodenal ulcerations as a delayed complication of hepatic metastasis radioembolization.
Topics: Adenocarcinoma; Brachytherapy; Cecal Neoplasms; Female; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Middle Aged; Peptic Ulcer; Yttrium Radioisotopes | 2010 |
Biodistribution and dosimetry of In-111/Y-90-HuCC49ΔCh2 (IDEC-159) in patients with metastatic colorectal adenocarcinoma.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Neoplasm; Colorectal Neoplasms; Female; Humans; Immunotoxins; Indium Radioisotopes; Male; Radioimmunotherapy; Radiometry; Radionuclide Imaging; Tissue Distribution; Yttrium Radioisotopes | 2011 |
Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases.
Topics: Adenocarcinoma; Antineoplastic Agents; Brachytherapy; Colorectal Neoplasms; Combined Modality Therapy; Embolization, Therapeutic; Female; Hepatectomy; Humans; Injections, Intra-Arterial; Liver Neoplasms; Microspheres; Radiography; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.
Topics: Adenocarcinoma; Animals; beta-Alanine; Binding, Competitive; Cell-Matrix Junctions; Dose-Response Relationship, Radiation; Drug Design; Female; Fibrinogen; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Integrin alpha5beta1; Integrin alphaVbeta3; Integrins; Jurkat Cells; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasms; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Radioisotopes; Radionuclide Imaging; Receptors, Vitronectin; Sulfonamides; Tissue Distribution; Vitronectin; Yttrium Radioisotopes | 2003 |
Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Body Weight; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Heterocyclic Compounds; Humans; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasms, Experimental; Organometallic Compounds; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Radioimmunotherapy; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2004 |
Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Middle Aged; Neoplasm Metastasis; Yttrium Radioisotopes | 2004 |
Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antineoplastic Agents; Benzamides; Colorectal Neoplasms; Female; Humans; Imatinib Mesylate; Immunotoxins; Iodine Radioisotopes; Mice; Mice, Nude; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radioimmunotherapy; Receptor, Platelet-Derived Growth Factor beta; Swine; Tissue Distribution; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2005 |
Portal hypertension secondary to 90Yttrium microspheres: an unknown complication.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Hepatectomy; Humans; Hypertension, Portal; Liver Neoplasms; Male; Microspheres; Organoplatinum Compounds; Oxaliplatin; Radiopharmaceuticals; Yttrium Radioisotopes | 2005 |
Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Embolization, Therapeutic; Gastrointestinal Tract; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Peptic Ulcer; Peptic Ulcer Hemorrhage; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2007 |
Selective internal radiation therapy: a case of SIR-Sphere associated duodenal ulceration.
Topics: Adenocarcinoma; Brachytherapy; Colorectal Neoplasms; Duodenal Ulcer; Female; Humans; Liver Neoplasms; Microspheres; Middle Aged; Yttrium Radioisotopes | 2007 |
The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2008 |
An uncommon cause of gastro-duodenal ulceration.
Topics: Adenocarcinoma; Gastric Mucosa; Humans; Intestinal Mucosa; Liver Neoplasms; Peptic Ulcer; Radionuclide Imaging; Radiotherapy; Sigmoid Neoplasms; Yttrium Radioisotopes | 2008 |
Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability.
Topics: Adenocarcinoma; Animals; Capillary Permeability; Colonic Neoplasms; Dose-Response Relationship, Radiation; Evaluation Studies as Topic; Female; Humans; Immunoglobulin G; Immunotoxins; Iodine Radioisotopes; Male; Neoplasm Transplantation; Radioimmunotherapy; Radioisotopes; Rhenium; Transplantation, Heterologous; Tumor Cells, Cultured; Yttrium Radioisotopes | 1995 |
Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Female; Humans; Immunoglobulin Fab Fragments; Immunotoxins; Indium Radioisotopes; Iodine Radioisotopes; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Radiation Dosage; Radioimmunotherapy; Tissue Distribution; Transplantation, Heterologous; Uterine Cervical Neoplasms; Yttrium Radioisotopes | 1994 |
Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Autoradiography; Cell Division; Cell Hypoxia; Colonic Neoplasms; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Immunotoxins; Indium Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Radiation-Sensitizing Agents; Radioimmunoassay; Radioimmunotherapy; Tirapazamine; Tissue Distribution; Transplantation, Heterologous; Triazines; Yttrium Radioisotopes | 1993 |
Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Autoradiography; Colonic Neoplasms; Humans; Iodine Radioisotopes; Melanoma; Mice; Mice, Nude; Radioimmunodetection; Radioimmunotherapy; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Yttrium Radioisotopes | 1993 |
Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targeting.
Topics: Adenocarcinoma; Animals; Avidin; Beta Particles; Biotin; Bone and Bones; Colonic Neoplasms; Humans; Liver; Male; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Time Factors; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 1997 |
Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Apoptosis; Breast Neoplasms; Dose-Response Relationship, Radiation; Female; Heterocyclic Compounds; Humans; Lethal Dose 50; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Radioimmunotherapy; Transplantation, Heterologous; Tumor Suppressor Protein p53; Yttrium; Yttrium Radioisotopes | 1998 |
DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Carcinoid Tumor; Cell Membrane; Colonic Neoplasms; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms; Pancreatic Neoplasms; Peptides, Cyclic; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Thyroid Neoplasms; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes | 1999 |
Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.
Topics: Adenocarcinoma; Feasibility Studies; Female; Humans; Male; Radioimmunotherapy; Time Factors; Yttrium Radioisotopes | 2000 |
Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Biotin; Dose-Response Relationship, Radiation; Humans; Indium Radioisotopes; Kinetics; Organometallic Compounds; Phantoms, Imaging; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Streptavidin; Tissue Distribution; Yttrium Radioisotopes | 1999 |
In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Autoradiography; Breast Neoplasms; Drug Stability; Female; Half-Life; Humans; Immunohistochemistry; Indium Radioisotopes; Iodine Radioisotopes; Isotope Labeling; Lewis Blood Group Antigens; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Radionuclide Imaging; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Yttrium Radioisotopes | 2000 |
Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Heterocyclic Compounds; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Organometallic Compounds; Radiopharmaceuticals; Radiotherapy Dosage; Tissue Distribution; Yttrium Radioisotopes | 2001 |
Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Carbon Radioisotopes; Carcinoembryonic Antigen; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Immunoconjugates; Immunoglobulin G; Iodine Radioisotopes; Luminescent Measurements; Mice; Mice, Nude; Neoplasms; Radioimmunodetection; Radioimmunotherapy; Radiometry; Radiotherapy Dosage; Sensitivity and Specificity; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 2001 |
A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colonic Neoplasms; Female; Humans; Indium Radioisotopes; Isotope Labeling; Mice; Mice, Nude; Neoplasm Transplantation; Radiopharmaceuticals; Resins, Synthetic; Sensitivity and Specificity; Strontium Isotopes; Tissue Distribution; Transplantation, Heterologous; Trastuzumab; Tumor Cells, Cultured; Yttrium Radioisotopes | 2002 |
Internal radiation therapy of liver cancer (90-Yttrium resin spheres intra-arterially) to supplement external radiation therapy, local and systemic chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Female; Fluorouracil; Humans; Liver Neoplasms; Lomustine; Male; Middle Aged; Vincristine; Yttrium Radioisotopes | 1977 |
Regression of liver metastases following treatment with yttrium-90 microspheres.
Topics: Adenocarcinoma; Adult; Aged; Carcinoembryonic Antigen; Chemotherapy, Cancer, Regional Perfusion; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiotherapy; Remission Induction; Yttrium Radioisotopes | 1992 |
Radiobiologic studies comparing Yttrium-90 irradiation and external beam irradiation in vitro.
Topics: Adenocarcinoma; Cell Division; Cell Line; Cell Survival; Cobalt Radioisotopes; Colonic Neoplasms; Dose-Response Relationship, Radiation; Humans; Kinetics; Yttrium Radioisotopes | 1991 |
Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Carcinoembryonic Antigen; Colonic Neoplasms; Disease Models, Animal; Female; Flow Cytometry; Immunotherapy; Mice; Mice, Inbred BALB C; Tumor Cells, Cultured; Yttrium Radioisotopes | 1991 |
Tolerance of the liver to the effects of Yttrium-90 radiation.
Topics: Adenocarcinoma; Brachytherapy; Colonic Neoplasms; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Radiation Tolerance; Yttrium Radioisotopes | 1990 |
Selective internal radiation therapy: distribution of radiation in the liver.
Topics: Adenocarcinoma; Angiotensin II; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Microspheres; Radiotherapy Dosage; Yttrium Radioisotopes | 1989 |
Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate.
Topics: Adenocarcinoma; Brachytherapy; Carcinoembryonic Antigen; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Humans; Liver Neoplasms; Yttrium Radioisotopes | 1989 |